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Abstract
Urothelial plaques are specialized membrane domains in urothelial superficial (umbrella) cells, composed of highly ordered
uroplakin particles. We investigated membrane compartments involved in the formation of urothelial plaques in mouse
umbrella cells. The Golgi apparatus did not contain uroplakins organized into plaques. In the post-Golgi region, three
distinct membrane compartments containing uroplakins were characterized: i) Small rounded vesicles, located close to the
Golgi apparatus, were labelled weakly with anti-uroplakin antibodies and they possessed no plaques; we termed them
‘‘uroplakin-positive transporting vesicles’’ (UPTVs). ii) Spherical-to-flattened vesicles, termed ‘‘immature fusiform vesicles’’
(iFVs), were uroplakin-positive in their central regions and contained small urothelial plaques. iii) Flattened ‘‘mature fusiform
vesicles’’ (mFVs) contained large plaques, which were densely labelled with anti-uroplakin antibodies. Endoytotic marker
horseradish peroxidase was not found in these post-Golgi compartments. We propose a detailed model of de novo
urothelial plaque formation in post-Golgi compartments: UPTVs carrying individual 16-nm particles detach from the Golgi
apparatus and subsequently fuse into iFV. Concentration of 16-nm particles into plaques and removal of uroplakin-negative
membranes takes place in iFVs. With additional fusions and buddings, iFVs mature into mFVs, each carrying two urothelial
plaques toward the apical surface of the umbrella cell.
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Introduction
Differentiation of the mammalian urothelium reaches its peak in
the superficial cell layer, which consists of large umbrella cells
[1,2,3]. Umbrella cells are unique for their luminal plasma
membrane, as 70–90% of its area is covered by urothelial plaques
[4,5,6]. The plaques are asymmetrically thickened membrane
domains (also known as asymmetric unit membrane – AUM) with
diameters of 600–1500 nm, separated by narrow rims of non-
thickened membranes, called hinge regions [7,8,9,10,11]. The
organization of uroplakins (UPs) in plaques [12,13] defines their
rigidity [14,15] and is of major importance for the proper
formation and maintenance of the urinary bladder’s permeability
barrier [16,17,18,19].
Urothelial plaques are also present in fusiform vesicles (FVs),
each containing two plaques [1,11,20,21]. FVs function as
transporting compartments for the delivery of urothelial plaques
to the apical plasma membrane [22,23,24,25,26,27,28]. During
bladder stretch, mechanoreceptors activate exocytosis of FVs by
purinergic signalling, modulated by cAMP, Ca2, extracellular
ATP, adenosine, the epidermal growth factor receptors and the
actin cytoskeleton [29].
By that means, 25–55% of cytoplasmic FVs are incorporated
into the apical plasma membrane [25], which makes its size
increase, and urinary bladder can accommodate filling with urine
[27,30]. It has been shown that Rab 27b, Rab11a, syntaxin-1,
SNAP-23 and synaptobrevin play important roles in apical
targeting of FVs [31,32,33].
FVs may also be formed by endocytosis during contractions of
the urinary bladder [25,34]. Upon voiding, the redundancy of the
apical plasma membrane is internalized and [1,9] designated for
degradation in lysosomes [35,36,37].
Two hypotheses have been put forward to explain a
biosynthetic origin of urothelial plaques. According to the first
one, it has been assumed that thickened membranes assemble in
Golgi cisternae from the cis-t ot h etrans- side, and eventually trans-
cisternae mature into FV [8,9,38]. Finally, the FV detaches from
the Golgi stack [1]. According to the second hypotheses [39],
urothelial plaque assembly begins with the synthesis of four major
uroplakins (UPIa, UPIb, UPII and UPIII) [12,13], followed by
the formation of UPIa/UPII and UPIb/UPIII dimers in the
endoplasmic reticulum [40,41,42,43,44]. In the Golgi apparatus,
two N-glycosylation sites on the UPII pro-sequence are converted
into complex glycans [45], which results in the tethering of
dimers into the heterotetramers (UPIa/UPII-UPIb/UPIII) [39].
It is assumed that by cleavage of the UPII pro-sequence into the
trans-Golgi network, heterotetramers assemble into a 16-nm
uroplakin particle [46] and particles are arranged into urothelial
plaques in the post-Golgi compartments [5,10,47]. The matura-
tion stages of urothelial plaques, following the exit of the
heterotetramers out of the Golgi apparatus, have not been shown
in umbrella cells.
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23636In this study, we used for the first time a combination of
uroplakin immunocytochemistry, freeze-fracturing and electron
tomography to study the formation of urothelial plaques. We
showed that plaques in the biosynthetic pathway form gradually in
the individual post-Golgi compartments, termed: ‘‘uroplakin-
positive transporting vesicles’’, ‘‘immature fusiform vesicles’’, and
‘‘mature fusiform vesicles’’. Based on our data, we propose a novel
model of urothelial plaque formation, which includes the fusion of
post-Golgi compartments, sorting of uroplakin-positive mem-
branes and removal of uroplakin-negative membranes.
Materials and Methods
All animal experiments were approved by the Veterinary
Administration of the Slovenian Ministry for Agriculture and
Forestry (permission no. 34401-5/2009/4), and were in accor-
dance with European guidelines and Slovenian legislation.
Urinary bladders of 6–8 weeks old male C57B6 mice,
anaesthetized with CO2, were excised and immediately processed
for microscopy. Five animals were sacrificed for studies of
ultrastructure, 2 for each immuno-electron and immunofluores-
cence labelling study, and 3 for horseradish peroxidase internal-
ization studies. At the time of sacrifice, the bladders contained less
than 50 ml of urine, and were considered physiologically empty
and contracted.
Electron tomography
For high pressure freezing, bladders were removed immediately
after death, tissue was impregnated with 6-hexadecene and cut
into pieces with a diameter 2 mm and a thickness 200 mm.
Samples were frozen with liquid nitrogen at 2100 bar in a Balzers
HPM 010 apparatus. Freeze-substitution was done in the
Automatic Freeze-Substitution System (EM AFS, Leica), following
the protocol of Monaghan et al [48]. Briefly, samples were heated
from 2160 to 290uC (14 h, +5uC/h) and, at 290uC, acetone
containing 2% OsO4 was introduced. Substitution/fixation was
performed as: 8 h, 290uC; 6 h, +5uC/h; 8 h, 260uC; 6 h, +5uC/
h; 8 h, 230uC. At 230uC, the acetone/OsO4 solution was
replaced by fresh acetone and samples were then heated to +20uC
(10 h, +5uC/h; 8 h, +20uC) and embedded in Epon.
Electron tomography was performed on 300 nm thick sections
with a FEI Tecnai 20 TEM microscope, running at 200 kv.
Tomograms covered angles between +65u and 265u in 1u steps.
Micrographs were taken at a 65006 magnification, resulting in
pixel size 2.72 nm. Modelling was done with Imod software
(http://bio3d.colorado.edu/imod/). Projections of 3-D models of
the Golgi apparatus and post-Golgi compartments are presented
in the results section.
Freeze-fracture
Urinary bladders were cut into ,1m m
3 pieces and fixed in
4% PA+2% GA in 0.1 M cacodilate buffer for 3 hours at 4uC.
After washing, samples were cryoprotected by incubation in 15%
and 30% glycerol in 0.1 M cacodilate buffer, and frozen in liquid
nitrogen. Fracturing was done on a freeze-etch machine Balzers
BAF200 at 2150uC .E x p o s e ds u r f a c e sw e r es h a d o w e dw i t h
platinum at a nominal angle of 45u and further strengthened by
carbon shadowed at a 90u angle. Replicas were transferred to
room temperature, cleaned in 5% NaOH for 30 min at 70uCa n d
in 10% ethanol for 20 min at room temperature. Replicas were
put on copper microscopic grids and were examined with a
Philips CM100 transmission electron microscope, running at
80 kV.
Immuno-electron microscopy
Cryo-ultrathin sections were prepared by modified Tokuyashu
method and labelled with anti-AUM rabbit polyclonal antibodies,
generated against mature bovine uroplakins (a kind gift from Prof.
T.T. Sun, University of New York, USA). Anti-AUM antibody
reacts strongly with UPIIIa, moderately with UPIa and weakly
with UPII [12]. Urothelium, cut into ,1m m
3 pieces, was fixed in
4% PA+0.1% GA in 0.1 M phosphate buffer for 2 hours, washed
in PBS, embedded in 12% gelatine and cryoprotected by
incubation in 2.3 M saharose. Samples were then stored in liquid
nitrogen. Samples were subsequently cut with a Leica FCS cryo-
ultramicrotom at 2120uC, and processed for immunolabelling.
Non-specific labelling was blocked by 0.8% BSA, 0.1% fish
gelatine and 5% fetal calf serum in PBS at room temperature for
30 min. Primary rabbit polyclonal antibodies against AUM
(diluted 1:10000) were incubated overnight at 4uC, washed in
PBS, and incubated with goat anti rabbit secondary antibodies,
conjugated with 10 nm colloidal gold (Sigma, diluted 1:40), at
room temperature for 1.5 h. Negative controls were done by
omitting the primary antibodies, by incubation in rabbit serum, or
by using inadequate primary antibodies. All cryo-ultrathin sections
were examined with a Philips CM100 transmission electron
microscope, running at 80 kV.
Immunofluorescence labelling
Bladder whole-tissue urothelium was prepared as described
previously [49]. Briefly, the bladder was cut into quarters, fixed in
4% paraformaldehyde in PBS, permeabilized with triton X-100
and immunolabelled with mouse IgG1 monoclonal anti-GM130
(BD Transduction Laboratories). Samples were then washed in
PBS, incubated with AlexaFlour 488 goat anti-mouse secondary
antibodies for 1.5 h, washed in PBS, and covered by VectaShield
fluorescent mounting media containing DAPI. Prepared whole-
tissue samples were mounted on glass slides with the apical surface
of urothelium upwards, facing the lens.
For thin-section immunofluorescence labelling, urothelium was
fixed as for immuno-electron microscopy and cut perpendicularly
to the urothelial luminal surface into 300 nm thick sections using a
Leica FCS cryo-ultramicrotom. Sections were incubated with
monoclonal anti-giantin (BD Transduction Laboratories) and
rabbit anti-AUM primary antibodies, followed by incubation with
AlexaFlour 488 goat anti-mouse and AlexaFlour 488/555 goat
anti-rabbit secondary antibodies. Negative controls were done by
omitting the primary antibodies, by incubation in rabbit serum, or
by using inadequate primary antibodies. Finally, slides were
mounted with VectaShield (Vector laboratories) containing DAPI
and visualized with a Nikon T300 or Zeiss AxioImager.Z1
microscope equipped with ApoTome upgrade.
Horseradish peroxidase internalization
Mice were anaesthetized with ketamine-xylazine. In order to
label the endocytotic membrane compartments involved in
internalization of the apical plasma membrane, horseradish
peroxidase (HRP, type II; SigmaAldrich) was instilled into the
mouse urinary bladders. HRP was diluted in Krebs-Ringer
medium (10 mg/ml) and 250 ml of this solution was slowly (over
2 minutes) instilled into the bladder with a syringe and catheter.
After 2 hours, bladders were excised, thoroughly washed in cold
Krebs-Ringer medium, cut into small pieces and fixed in 2.5% GA
in 0.1 M cacodilate buffer. HRP was detected by DAB reaction.
Samples were post-fixed in 1% OsO4 with 1% ferrocyanide in
0.1 M cacodilate buffer, dehydrated and embedded in Epon.
Negative controls were done as above, except that HRP was
omitted from the Krebs-Ringer medium. Ultrathin sections were
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80 kV.
Quantitative analysis
Urinary bladders were sagitally divided into two halves; one half
was prepared for ultrathin sections (see Electron tomography) and
the other for freeze-fracture replicas (see Freeze-fracture).
Ultrathin sections (60 nm thick) were prepared from two Epon
blocks of each animal and micrographs of 10 umbrella cells were
taken at a magnification 210006in a Philips CM100 microscope,
running at 80 kv. We measured only the profiles of post-Golgi
compartments that had membranes visible as two lipid layers
around the whole compartment and that contained thickened
membranes. By the first requirement, we ensured that vesicles
were cut through their centre, and by the second that the analysed
post-Golgi compartments contained urothelial plaques [2,3,50].
Measurements (twenty-five to fifty for each compartment) were
done on a personal computer using ImageJ ver. 1.44 software for
Windows [51]. The surface, intraluminal volume, and their ratio
were calculated taking into consideration that membrane
compartments are revolving geometric bodies and that the shape
of UPTVs is limiting towards a sphere, iFV towards an ellipsoid,
and the shape of mFVs is limiting towards a circular cylinder.
On freeze-fracture replicas, micrographs of umbrella cells were
taken at a magnification 285006. For analysis we only took into
account vesicles that contained 16 nm particles [11,14,47].
Particle counting and surface measurements to calculate particle
density (twenty to thirty for each compartment) were done using
ImageJ software.
Statistical analyses were performed with Microsoft Office Excel
2007 software. Statistical significance was tested with Student’s t-
test.
Results and Discussion
In our study, we analysed superficial urothelial cells that
contained a well-developed Golgi apparatus, fusiform vesicles and
strong anti-AUM immunolabelling reactions. We studied the
membrane compartments in these cells, which participate in the
biosynthesis of urothelial plaques that cover the apical plasma
membrane. Based on the ultrastructure and immunolabelling, we
showed that specific post-Golgi compartments, including ‘‘uropla-
kin-positive transporting vesicles’’ (UPTVs), ‘‘immature fusiform
vesicles’’ (iFVs), and ‘‘mature fusiform vesicles’’ (mFVs), contribute
to urothelial plaque formation.
The Golgi apparatus is not the site of final plaque
formation
The role of the Golgi apparatus (GA) in the process of urothelial
plaque formation has been indicated by early morphological
[8,9,38] and biochemical studies [39,46]. We recently described
the role of GA distribution and organization in the differentiation
of urothelial cells [49]. Here we provide arguments that the GA is
not the site of final plaque formation.
A top viewofanti-GM130 immunolabelled umbrellacellsrevealed
that the GA was spread over the central cytoplasm of umbrella cells
and formed a network (Fig. 1A; negative controls were negative and
are shown in Fig. S1A). That has been shown to be characteristic of
the terminal differentiation of urothelial cells [49,52]. By analysing
the ultrastructure, a typical umbrella cell was shown to contain
multipleinterconnected GAs; an individual GAwas composed of 5–9
aligned cisternae (Fig. 1B). Plaques of asymmetrically thickened
membrane were not seen in the Golgi cisternae (Figs. 1B, C). Since
thickened plaques were detectable in the post-Golgi compartments
and on the apical plasma membrane, plaques would also be visible in
the Golgi cisternae, if they were present.
A second argument against the GA as the site of final plaque
formation came from electron tomography studies. Three-
dimensional reconstructions by electron tomography revealed that
Golgi cisternae were uniformly flattened in their centre (Fig. 1D).
On the other hand, trans-cisternae and the trans-Golgi network
(TGN) contained tubulo-vesicular extensions (rims; Fig. 1E,
Videos S1, S2). The size and curvature of the extensions conflicts
with the description of FVs, which are uniformly flat and never
possess a significant intravesicular lumen. The 3-D reconstruction
of the GA and surrounding compartments thus provides
morphological evidence that Golgi cisternae do not directly
mature into FVs [1,8,9,38].
In order to see uroplakin particle accumulation in the GA, we
used anti-AUM antibody, which is generated against total mature
uroplakins. Double immunolabelling showed no co-localization of
anti-AUM and anti-giantin antibodies (Fig. 1F; negative controls
were negative and are shown in Fig. S1B). Although a section
thickness of 300 nm provided high Z-axis resolution, we wanted to
correlate the immunolabelling signal of the uroplakins with the
ultrastructure of the GA. We labelled cryo-ultrathin sections with
anti-AUM antibody, which again demonstrated no labelling of the
Golgi cisternae (Fig. 1G; negative controls were negative and are
shown in Fig. S1C). Labelling was observed in the tubulo-vesicular
structures of the trans-Golgi network and in the post-Golgi
compartments (Fig. 1G). Previous freeze-fracture studies have
shown similar results; namely no accumulations of uroplakin
particles in the GA [10]. Immunolabelling thus provides evidence
that uroplakins become mature in the trans-Golgi network, as had
been predicted by biochemical studies of uroplakin glycosylation
[39,46]; however, they are concentrated in mature plaques in the
post-Golgi compartments.
Uroplakin-positive transporting vesicles carry newly
formed uroplakin particles
Vesicles with an average diameter of 86 nm were noticed next
to trans-Golgi cisternae (Fig. 2A, Table 1). Three-dimensional
reconstructions disclosed that membrane compartments, which
appeared as vesicles on thin sections, were distinct, spherical or
slightly elongated (Fig. 2B, Videos S1, S2).
Although urothelial plaques were not detected in these small
vesicles, immunolabelling showed that some of them were anti-
uroplakin positive (Fig. 2C). We therefore designated these post-
Golgi compartments ‘‘uroplakin-positive transporting vesicles’’
(UPTVs). The low concentration of uroplakin particles in the
membranes of UPTVs (414 per nm
2) allow UPTVs to curve into
small-diameter spherical shapes (Table 1). Such curving would be
impossible with a high number of particles concentrated into
mature plaques (1109 per nm
2), which are rigid two-dimensional
crystals [14,15,53]. Analysing the ultrastructure and freeze-
fracture replicas of umbrella cells, UPTVs were observed close
to each other (Fig. 2D) or close to iFV; this position suggests homo-
and heterotypic fusions of membranes. Fusions of UPTVs would
form bigger iFVs, carrying more uroplakin particles.
Immature fusiform vesicles sort membranes and
concentrate uroplakin particles
The term FV is used to describe dilated spherical-to-discoidal or
flattened vesicles with asymmetrically thickened membranes
[4,9,16,19,29,32,49,50,52,54,55]. In our study, we distinguished
two sub-populations of FVs: the first were termed ‘‘immature FVs’’
(iFVs), and the second as ‘‘mature FVs’’ (mFVs). iFVs were
Urothelial Plaque Formation
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vesicles, containing various lengths of morphologically recogniz-
able plaques of AUM (Fig. 3). iFVs represent the sub-population of
vesicles that have been described elsewhere by their assortment of
profiles, e.g., dilated, spherical or discoidal vesicles
[4,5,8,19,29,50]. Comparing those vesicles with mFVs, it was
evident that iFVs had a smaller overall size (average 439 vs.
958 nm), shorter length of plaques (average diameter 327 vs.
851 nm, occupying 65 vs 86% of the circumference length) and
larger intraluminal volume (surface: intraluminal volume ratio
0,078 vs 0,423; Tables 1, S1), which shows that iFVs are distinct
post-Golgi compartments. In order to distinguish iFVs from
mFVs, we recommend the term iFVs when referring to the
population of heterogeneous membrane compartments with a
central role in plaque formation; namely, intensive membrane
adding, sorting and concentration of the uroplakin particles, as
described below.
Adding uroplakin particles to iFVs is carried out by UPTVs.
UPTVs in the GA region were close to each other and, next to
them, small, individual iFVs were observed (Figs. 3A, H). Larger
iFVs were flattened and were typically arranged in stacks of 3 to 10
vesicles, positioned parallel to each other (Figs. 3A, B, I, Videos
S1, S2). Stacks were polarized in the sense that they incorporated
smaller, dilated vesicles at one side, and larger, uniformly flattened
vesicles at the other side of the stack (Figs. 3A, D). The intensity of
anti-AUM labelling increased in larger, stacked iFVs compared to
UPTVs and smaller iFVs (Fig. 3C). The rims of stacked iFVs were
made of non-thickened membranes, which were uroplakin-
negative (Fig. 3C) and frequently possessed dilatations (Fig. 3D).
The diameter of the dilatations was approximately 100 nm, which
corresponded to the size of UPTVs and to small, uroplakin-
negative vesicles that were also found next to the GA. That implies
that fusions of UPTVs with iFVs, and the detachment of
uroplakin-negative vesicles from them, could be a mechanism of
uroplakin particle delivery to the growing urothelial plaque. An
alternative way of obtaining larger plaques would be direct
membrane connections between the GA and iFVs, by which
uroplakin particles would move. We employed electron tomogra-
Figure 1. Uroplakins are not accumulated in the Golgi cisternae, but in the post-Golgi compartments. A) Top-view on the umbrella cell
immunolabelled with anti-GM130 (green) shows a GA network spread across the whole cytoplasm. B) Plaques of asymmetric thickened membrane
are not seen in the Golgi cisternae. C) Inset shows higher magnification of GA part, which has membranes 8–9 nm thick. D and E) Optical sections
created from electron tomogram reconstruction, with superimposed models of the GA. D) GA forms flattened, occasionally fenestrated cisternae of
various lengths (violet). E) From the rims of trans-Golgi cisterne and from the trans-Golgi network emanate tubulo-vesicular extensions (gold; GA
cisternae are violet). F) Double immunolabelling with anti-gianti antibody (green, arrows) and anti-AUM antibody against mature uroplakins (red),
shows no colocalization in the umbrella cell. GA (arrows) lies lateral to the nucleus, while uroplakins are seen throughout the cytoplasm (*) and on the
apical surface (arrow-head). G) Labelling of cryo-ultrathin sections with anti-AUM antibody is negative in the GA and positive in post-Golgi
compartments (arrows). Legend: M – mitochondria; blue – nucleus (DAPI). Bars 10 mm in A, F, 200 nm in B, G. Tomogram for D, E was taken at 65006.
doi:10.1371/journal.pone.0023636.g001
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between the GA and iFVs (Figs. 3H, I).
Sorting urothelial plaques takes place in 2 regions of iFVs: the
centre and rims. Results showed that plaques occupied the central
parts of iFVs, while their rims were composed of non-thickened
membranes (Figs. 3E, F). Plaques opposed each other at the
parallel sides of the vesicle; however, the sides of the vesicle were
not identical. There were differences in plaque lengths and in
plaque number between the sides of the vesicles, i.e., one side
contained a few smaller plaques, separated by non-thickened
membranes, while the other side had a single large plaque (Fig. 3E).
These observations were further supported by analysing freeze-
fracture replicas, whereby it was noted that the diameter of the
plaque area (3276203 nm) and the number of uroplakin particles
(5506350 per mm
2 ) varied also among iFVs of the same size
(Fig. 3G, Table 1, S1); the same was observed by Severs and Hicks
[10], and provides further evidence of the progressive maturation
of urothelial plaques in iFVs.
The heterogeneity of shape and size of iFVs correlated with the
amount of thickened membranes they contained (Tables 1, S1).
The more non-thickened membranes a vesicle contained, the
smaller and more spherical was its appearance, and vice-versa, the
larger the plaques contained in a vesicle, the larger and more
flattened was its appearance (Table 1, S1). That observation is in
agreement with the finding that uroplakin particle concentration
and the size of the urothelial plaque are determined by the force
equilibrium of head-to-head interactions between neighbouring
uroplakin particles and local surface tensions [14]. Uroplakin
particles are thereby progressively added to iFVs and aggregate
until the final size of the urothelial plaque is reached in mFVs.
These results support the hypothesis that iFVs are the site of
intensive membrane sorting and concentration of uroplakin
Figure 2. Mature uroplakins are first detected in UPTVs. A) UPTVs are post-Golgi compartments (black arrows), which are positioned next to
the GA. Rims of some GA cisternae have coated membranes (white arrow). B) Projection of 3-D model shows that UPTVs are individual rounded
membrane compartments (green; trans-Golgi network is gold). C) Sparse mature uroplakins are detected in UPTVs (arrows) and in the small iFVs
(bigger arrows) next to the GA. Some iFVs are densely anti-AUM labelled. D) Freeze-fracture of umbrella cells shows UPTVs (arrows), which are
positioned close to each other suggesting fusions of vesicles (white arrow). Larger iFVs carry numerous protein particles gathered into urothelial
plaques (*). Arrow in circle indicates direction of Pt shadowing. Bars 200 nm.
doi:10.1371/journal.pone.0023636.g002
Table 1. Characteristics of post-Golgi compartments involved
in the formation of urothelial plaques.
Class of vesicle UPTVs iFVs mFVs
Major diameter (nm) 86 (9) 439 (201)1 958 (194)*
Surface: intraluminal volume ratio 0,129 0,078 0,423
Particles density in vesicles per mm
2 414 (216) 550 (350) 1109 (398)*
Plaque : non-thickened
membranes ratio
- 2,73 (1,98) 8,78 (5,73)*
Plaque length : circumference length, % - 65 (17) 86 (8)*
Legend: in brackets - standard deviation,
1- statistically significant UPTVs:iFVs,
*- statistically significant iFVs:mFVs.
doi:10.1371/journal.pone.0023636.t001
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PLoS ONE | www.plosone.org 5 August 2011 | Volume 6 | Issue 8 | e23636Figure 3. Spatial and size correlations between UPTVs, iFVs and mFVs suggest gradual formation of urothelial plaques in the
biosynthetic pathway. A) UPTVs (arrows) and small iFVs (1) accumulate next to the polarised stack of larger iFVs (2) and mFVs (3). B) Freeze-fracture
replica showing polarized stack of iFVs. Arrow in circle indicates direction of Pt shadowing. C) Uroplakin particles accumulate progressively from
UPTVs, over iFVs to mFVs. UPTVs and smaller iFVs (black arrows) are detected next to larger iFVs. The central region of these vesicles shows heavy
anti-AUM labelling (big arrow), while the rims remain uroplakin negative (white arrows). Note anti-AUM negative rounded vesicles (striped arrows)
that might be involved in plaque formation by removing the excess of non-thickened membranes from maturing FVs. D) iFVs have vesicular
Urothelial Plaque Formation
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which has a central role in plaque formation. Compartments that
succeed iFVs, i.e., mFVs, have a role in the transport of mature
plaques between cytosol and the apical plasma membrane.
Mature fusiform vesicles are the final stage of plaque
formation
mFVs were the most abundant membrane compartments of
umbrella cells that were investigated in our studies. The presence of
mFVs was evidence that cells are terminally differentiated and
therefore represent typical umbrella cells of the bladder [3,19]. The
mFVs analysed here were on average <950 nm long, and in sectional
profile uniformly flattened, coin-like vesicles (Tables 1, S1, Fig. 4A).
mFVs were gathered into stacks (Figs. 4A) or they were found as
individual compartments. They have a high surface-to-volume
ratio (Table 1). The surface of an average mFV had increased by
480% compared to an iFV, while its intraluminal volume
simultaneously decreased by 13% (Table S1).
In agreement with the literature [1,19,29,50], observed mFVs
contained two urothelial plaques, connected by a non-thickened
‘hinge’ region at their rims (Fig. 4A). Each plaque consisted of
hexagonally ordered 16 nm urothelial particles (Fig. 4C). Quanti-
tative analysis showed that the size of a plaque was on average 2,6
times bigger,and the number of particles per plaque was on average
2 times higher, in mFVs than in iFVs (Tables 1, S1). This supports
the idea that mFVs represent the final stage of plaque formation.
The majority of urothelial plaques are of biosynthetic
origin
Urothelial plaques can origin from de novo formation in the
biosynthetic pathway or from internalization of the apical plasma
membrane [25,34]. In order to distinguish membrane compart-
ments of the biosynthetic pathway from those of the endocytotic
pathway, we analysed umbrella cells after HRP instillation into the
urinary bladder lumen. After two hours of endocytosis from the
apical plasma membrane, HRP-reaction products were found only
sparsely inside the cells. As has also been observed elsewhere
[37,56], only some small rounded vesicles in the subapical region
and multivesicular bodies were labelled with HRP-reaction
products (Fig. 3D; negative controls were negative and are shown
in Fig. S1D). HRP-reaction products were not detected in iFVs,
mFVs or in any structure in the GA region. This is in agreement
with studies of Kreft et al [52], which show that the rate of
endocytosis from the apical plasma membrane decreases as
Figure 4. mFVs present the final stage of urothelial plaque formation. A) On the micrograph are shown mFVs organized into a stack. mFVs
have a narrow intravesicular lumen and un-dilated rims. B) Projection of 3-D model shows difference in size and shape between bigger iFV (yellow)
and mFVs (red). C) mFVs have urothelial plaques (*) positioned centrally. Note flattened, coin-like shape of the mFV. Arrow in circle indicates direction
of Pt shadowing. D) After two hours of endocytosis, the HRP reaction product is present in a multivesicular body (arrow), while the majority of
multivesicular bodies (arrow-heads) and all of the FVs remain un-labelled. Bars 500 nm.
doi:10.1371/journal.pone.0023636.g004
dilatations (arrow-heads) and vesicles are seen in their vicinity (arrows), suggesting intense vesicular traffic . E) Various sizes of plaques of
asymmetrically thickened membrane (black arrows) in iFVs are seen on ultra-thin section. Asymmetrically thickened membrane (12 nm thick) lines
the central regions of iFVs, while non-thickened membranes (arrow-heads) line the rims of iFVs and separates plaques. Domains of non-thickened
membrane appear dilated. F) At higher magnification, 12 nm thick plaque (arrow) and 9 nm thick hinge regions (arrow-head) are seen. G) Smaller
iFVs (arrow-heads) and three larger iFVs, which contain a remarkably varied number of protein particles (black arrows) in their plaques. iFVs that
contain a high number of particles (*) in their plaques, contain only a small amount of particle-free membranes (w). White arrow shows close
proximity of a smaller and bigger iFV, a position suggesting their fusion, thus increasing the number of uroplakin particles. H and I) Optical sections
created from electron tomogram reconstruction, with superimposed models of iFVs. H) UPTVs are positioned close to each other (green), and next to
small iFV (blue). I) Small iFVs (blue) are spherical or ellipsoid, while bigger iFVs (yellow) are flattened. Bars 200 nm, 500 nm in B, G.
doi:10.1371/journal.pone.0023636.g003
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minimum in the terminally differentiated umbrella cells.
Our study therefore shows that the majority of urothelial
plaques are of biosynthetic and not endocytotic origin.
Conclusion
Umbrella cells, as highly specialized non-secreting epithelium [1],
are a unique in vivo model for studies of membrane formation,
maturation and the dynamics of polarized traffic [19,21,29,50]. We
have here combined microscopical methods to gain insights into the
formation of urothelial plaques in mouse umbrella cells. Our results
indicate that urothelial plaques have a predominantly biosynthetic
origin. The GA is the site of uroplakin glycosylations, their
conformation changes and tetramerization [39]; however, it is not
the site of plaque formation. Instead, we propose an improved model
(Fig. 5) of progressive plaque formation in three distinct post-Golgi
compartments: i) ‘‘uroplakin-positive transporting vesicles’’ transport
individual uroplakin particles and are fused into ‘‘immature fusiform
vesicles’’ (initial stage of plaque formation). ii) In immature fusiform
vesicles, uroplakin particles are concentrated into plaques and
uroplakin-negative membranes are removed (adding, sorting and
concentrating membranes; the central stage of plaque formation). iii)
When the urothelial plaque reaches its final size, immature fusiform
vesicles are transformed into ‘‘mature fusiform vesicles’’ (final stage of
plaque formation) and stored urothelial plaques can be transported
into the apical plasma membrane of umbrella cells.
Supporting Information
Figure S1 Negative controls. A) Negative control for anti-
GM130 immunolabelling. No green color (anti-GM130) is seen in
umbrella cells. B) Negative control for anti-giantin and anti-AUM
immunolabelling. No green (anti-giantin) or red (anti-AUM) color
is seen in umbrella cells. C) Negative control for anti-AUM
immunolabelling on cryo-ultra thin sections. No gold particles on
mFV or on the apical plasma membrane of umbrella cells (arrow).
D) Negative control for HRP internalization experiment. Note, no
black HRP-reaction products are seen on the apical plasma
membrane or in the cytoplasm of umbrella cells. Legend: blue –
nucleus (DAPI). Bars: 10 mm in A, B, 500 nm in C, D.
(TIF)
Video S1 Three-dimensional reconstruction of Golgi
apparatus and post-Golgi compartments in the umbrel-
la cell.
(WMV)
Video S2 Three-dimensional model of Golgi apparatus
and post-Golgi compartments involved in the formation
of urothelial plaques in the umbrella cell.
(WMV)
Table S1 Characteristics of post-Golgi compartments
involved in the formation of urothelial plaques (extend-
ed).
(DOCX)
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